Cargando…
Cdk6 contributes to cytoskeletal stability in erythroid cells
Mice lacking Cdk6 kinase activity suffer from mild anemia accompanied by elevated numbers of Ter119(+) cells in the bone marrow. The animals show hardly any alterations in erythroid development, indicating that Cdk6 is not required for proliferation and maturation of erythroid cells. There is also n...
Autores principales: | Uras, Iris Z., Scheicher, Ruth M., Kollmann, Karoline, Glösmann, Martin, Prchal-Murphy, Michaela, Tigan, Anca S., Fux, Daniela A., Altamura, Sandro, Neves, Joana, Muckenthaler, Martina U., Bennett, Keiryn L., Kubicek, Stefan, Hinds, Philip W., von Lindern, Marieke, Sexl, Veronika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451331/ https://www.ncbi.nlm.nih.gov/pubmed/28255017 http://dx.doi.org/10.3324/haematol.2016.159947 |
Ejemplares similares
-
CDK6 Inhibition: A Novel Approach in AML Management
por: Uras, Iris Z., et al.
Publicado: (2020) -
Inducible deletion of CDK4 and CDK6 – deciphering CDK4/6 inhibitor effects in the hematopoietic system
por: Maurer, Barbara, et al.
Publicado: (2020) -
The role of CDK6 in cancer
por: Nebenfuehr, Sofie, et al.
Publicado: (2020) -
CDK6 and p16(INK4A) in lymphoid malignancies
por: Kollmann, Karoline, et al.
Publicado: (2013) -
CDK4/6 and MAPK—Crosstalk as Opportunity for Cancer Treatment
por: Scheiblecker, Lisa, et al.
Publicado: (2020)